Dawn I. Velligan, PhD

JCP
The Emerging Treatment Landscape in Schizophrenia
Commentary

January 18, 2023

This article provides an overview of emerging therapies poised to transform the treatment paradigm for patients with living with schizophrenia.
Dawn I. Velligan, Sanjai Rao
JCP
Schizophrenia: Salient Symptoms and Pathophysiology
Commentary

January 18, 2023

This article notes the distinction between positive and negative schizophrenic symptoms and provides an updated overview of disease pathophysiology.
Dawn I. Velligan, Sanjai Rao
JCP
Adverse Events and Treatment Adherence in Schizophrenia
Commentary

January 18, 2023

This article examines the effects of treatment-related adverse events on adherence to medication and strategies to improve adherence in practice.
Dawn I. Velligan, Sanjai Rao
JCP
The Epidemiology and Global Burden of Schizophrenia
Commentary

January 18, 2023

This article explores the costs and burden of schizophrenia and provides an overview of disease prevalence, incidence, and trends over time.
Dawn I. Velligan, Sanjai Rao
JCP
Optimizing Therapy Selection, Sequencing in Schizophrenia
Commentary

January 18, 2023

This article summarizes the current treatment landscape in schizophrenia, along with contexts in which agents should be prescribed.
Dawn I. Velligan, Sanjai Rao
JCP
Defining and Achieving Treatment Recovery in Schizophrenia
Commentary

January 18, 2023

This article defines treatment recovery in schizophrenia and summarizes strategies clinicians can pursue to improve patient outcomes.
Dawn I. Velligan, Sanjai Rao
JCP
Cognitive Impairment, Reward Pathways and Treatment Challenges in Schizophrenia Video
Insight videos

January 14, 2023

Evaluating different domains of negative symptoms separately to better understand their impact on functional outcomes, particularly cognitive symptoms, is important in the treatment of patients with schizophrenia, especially intervening...
Dawn I. Velligan, Sanjai Rao
JCP
Shared Decision Making in Schizophrenia Treatment Video
Insight videos

January 14, 2023

Although there are now multiple medications available to treat schizophrenia, many gaps still exist as a barrier to treatment success resulting in lower quality of life for this patient...
Dawn I. Velligan, Sanjai Rao
JCP
Original Research

June 24, 2015

Peter J. Weiden, Rebecca S. Roma, Dawn I. Velligan, et al
JCP
Article

July 31, 2009

Dawn I. Velligan, Peter J. Weiden, Martha Sajatovic, et al
JCP
Original Research

March 1, 2004

Philip D. Harvey, Michael F. Green, Richard S. E. Keefe, et al
JCP
Original Research

May 15, 2003

Dawn I. Velligan, Thomas J. Prihoda, Dawen Sui, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe